查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1974192

微量采样设备市场：按产品类型、样品类型、最终用户和分销管道划分 - 2026-2032年全球预测

Microsampling Devices Market by Product Type, Sample Type, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年微采样设备市场价值为 1.0615 亿美元，预计到 2026 年将成长至 1.1634 亿美元，复合年增长率为 7.49%，到 2032 年将达到 1.7603 亿美元。

主要市场统计数据
基准年 2025 1.0615亿美元
预计年份：2026年 1.1634亿美元
预测年份 2032 1.7603亿美元
复合年增长率 (%) 7.49%

不断发展的微量采样技术和分散式照护模式如何改变检体采集方式并重新定义临床和诊断工作流程。

微量采样技术已从一项小众的实验室新技术发展成为一种实用工具，彻底改变了临床研究、诊断和分散式医疗服务中的检体采集模式。过去十年间，毛细管采样光学、干血斑稳定化、微流体晶片工程和体积吸收微量采样等的技术进步，降低了对传统静脉穿刺和集中处理的依赖。这种转变为远端患者监护、简化检体物流以及以患者为中心的试验设计开闢了新的途径。

以使用者为中心的设计、数位化支援和监管规定的明确化，使得微量采样从先导计画发展成为综合性的临床和诊断实践。

微量采样领域经历了变革性的转变，这主要得益于技术创新、医疗服务模式的变革以及对病患​​体验日益增长的关注。仪器和耗材供应商致力于透过改进设计来降低分析前变异性，从而控制体积精度、减少血球比容的影响并提高检体均一性。同时，微流体晶片设计的进步使得以往需要手动检体处理步骤得以集成，从而拓展了微量样本在更复杂检测中的效用。

美国关税趋势变化对微量采样设备及耗材製造商和经销商的供应链、采购和生产决策的影响。

美国近期关税政策的变化为生产和销售微量采样设备及相关耗材的公司带来了更多挑战。医疗设备和检测设备组件的进口关税结构和分类指南的调整，正在影响依赖跨境供应链的供应商的成本基础，尤其是在精密组件、聚合物和特殊试剂领域。这些调整迫使采购部门重新评估其筹资策略和库存管理政策，以维持利润率和服务水准。

透过细分市场分析，明确对产品、通路和最终用户的影响，从而指导微抽样解决方案整体的策略优先排序和部署策略。

详细的細項分析揭示了设备和通道配置中临床效用、推广障碍和商业性机会的交汇点。按样本类型（毛细管采样、干血斑、微流体晶片、体积吸收微采样）进行的市场分析表明，每种方法都有其独特的分析相容性和用户体验方面的考虑。在微流体晶片子类别中，自动化取样解决方案和实验室晶片结构之间的差异凸显了处理能力和照护现场适用性之间的权衡。同样，在体积吸收微采样方案中，诸如Capitainer、HemaXis和Mitra等平台特定的实现方式在仪器依赖性、使用者训练要求和分析物稳定性方面也表现出不同的特性。

影响微采样技术的商业化、检验和运作准备的区域产品、监管和分销要求。

区域趋势对产品设计选择、监管准备和商业性市场进入策略有显着影响。在美洲，对分散式临床试验的日益重视以及居家医疗基础设施的扩展，推动了对使用者友善采样方法和能够管理分散式采集点的强大物流解决方案的需求。该地区的监管路径也在不断发展，以适应替代基质和远端采样，这影响供应商建构检验方案和客户支援服务的方式。

竞争格局洞察重点在于设备精度、检验伙伴关係以及服务丰富的商业模式，这些因素会影响供应商的选择和部署速度。

微量采样生态系统的竞争动态呈现出多元化的态势，既有专注于设备创新的专业厂商，也有不断拓展产品线的大型诊断公司，还有检验和标准化工作流程的合约实验室。产品差异化通常体现在采样量精度、血球容积比降低策略、使用者人体工学设计、与检查室自动化系统的整合能力等。能够提供卓越易用性、清晰的分析效能和可靠的检验数据的公司往往更受临床和科学研究客户的青睐。

要将微抽样技术的潜力转化为永续的应用，实际的策略重点必须包括产品设计和检验的严谨性、供应链的韧性以及通路的执行。

评估策略方案的领导者应着重采取切实可行的步骤，使产品开发、监管策略和商业性执行与实际部署限制相符。优先投资于可用性测试和人体工学，减轻训练负担，并确保可靠的患者主导型检体采集。将这些努力与严谨的方法检验研究和透明的文件结合，可以缩短诊断实验室和临床申办者的引进週期。

本研究旨在透过严格整合一手访谈、技术文献、监管指南和营运案例研究，产生可重复的决策见解。

本研究整合了访谈资料、技术文献、监管指南和营运案例研究，全面展现了微量采样技术的现况。主要资料来源包括对医疗机构和生命科学公司的实验室经理、临床营运经理、居家照护专案经理和采购专业人员的结构化访谈。这些访谈内容深入观点了可用性挑战、整合需求和检验重点，是技术性能数据的补充。

技术成熟度、营运准备情况以及协作检验的整合是决定微采样解决方案长期临床接受度和部署的关键因素。

微量采样技术正处于一个十字路口，技术成熟度、分散式医疗的发展趋势以及实际操作的可行性在此交汇融合。设备性能和微流体整合技术的不断进步拓展了毛细管采样和体积检测法的应用场景。同时，使用者支援和训练的改进降低了患者辅助采集检体的门槛。然而，随着关税和物流趋势对成本和供应链的影响，分销网络和供应链的韧性变得日益重要。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：微量采样设备市场：依产品类型划分

  • 配件
  • 消耗品
  • 装置
  • 成套工具

第九章：依样品类型分類的微量取样设备市场

  • 毛细管采样
  • 干血斑
  • 微流体晶片
    • 自动采样装置
    • 晶片实验室
  • 体积吸收微量取样
    • 资本家
    • 血轴
    • 米特拉

第十章：微量采样设备市场：依最终用户划分

  • CRO（受託研究机构）
  • 诊断检查室
  • 居家医疗
  • 医院
  • 製药公司
  • 研究机构

第十一章：微量采样设备市场：依分销管道划分

  • 直销
  • 销售代理
  • 线上管道

第十二章 微量采样设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 微量采样设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 微量采样设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国微量采样设备市场

第十六章：中国微量采样设备市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agilent Technologies, Inc.
  • AptarGroup, Inc.
  • Bio-Rad Laboratories, Inc.
  • Capitainer AB
  • Cardinal Health, Inc.
  • HemaXis
  • HTL-STREFA SA
  • LGC Limited
  • Medtronic plc
  • Merck KGaA
  • Neoteryx LLC
  • Nipro Corporation
  • Owen Mumford Ltd.
  • PerkinElmer, Inc.
  • Phenomenex, Inc.
  • Sarstedt AG & Co. KG
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Spot On Sciences, Inc.
  • Tasso, Inc.
  • Terumo Corporation
  • Thermo Fisher Scientific, Inc.
  • Trajan Scientific and Medical Pty Ltd
  • West Pharmaceutical Services, Inc.
Product Code: MRR-D97D8E0B50BE

The Microsampling Devices Market was valued at USD 106.15 million in 2025 and is projected to grow to USD 116.34 million in 2026, with a CAGR of 7.49%, reaching USD 176.03 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 106.15 million
Estimated Year [2026] USD 116.34 million
Forecast Year [2032] USD 176.03 million
CAGR (%) 7.49%

How evolving microsampling technologies and decentralized care models are shifting specimen collection practices and redefining clinical and diagnostic workflows

Microsampling technologies have evolved from niche laboratory curiosities into practical tools that are reshaping sample collection paradigms across clinical research, diagnostics, and decentralized care delivery. Over the past decade, technological refinements in capillary sampling optics, dried blood spot stabilization, microfluidic cartridge engineering, and volumetric absorptive microsampling have reduced reliance on traditional venipuncture and centralized processing. This transition has unlocked new pathways for remote patient monitoring, simplified specimen logistics, and more patient-centric trial designs.

Consequently, stakeholders across pharmaceutical development, diagnostic laboratories, and clinical care settings are reassessing their sample collection strategies to capture the clinical value of minimally invasive approaches. Adoption drivers include improved patient convenience, reduced cold-chain dependency for some analytes, and enhanced access to geographically dispersed cohorts. Importantly, these technologies are converging with digital health enablers-such as mobile apps for sample collection guidance and cloud-based data management-creating an ecosystem that supports scalable decentralized studies.

As the landscape matures, decision-makers must weigh operational trade-offs, including standardization of pre-analytical variables, integration with laboratory workflows, and regulatory alignment for new sample matrices. The introduction of automated samplers and lab-on-a-chip platforms is also shifting expectations for throughput and analytical fidelity, prompting laboratories and contract research organizations to evaluate their readiness for adoption. Looking ahead, the interplay between usability, assay compatibility, and regulatory confidence will determine which microsampling approaches achieve mainstream clinical acceptance.

The convergence of user-centric design, digital support, and regulatory clarity that has propelled microsampling from pilot projects into integrated clinical and diagnostic operations

The landscape for microsampling has experienced transformative shifts driven by technological innovation, shifting care delivery models, and an intensified focus on patient experience. Instrument and consumable suppliers have concentrated on reducing pre-analytical variability through design improvements that control volumetric accuracy, hematocrit effects, and sample homogeneity. Parallel advances in microfluidic cartridge design have enabled the integration of sample handling steps that were previously manual, expanding the utility of microsamples in more complex assays.

At the same time, healthcare delivery has decentralized: home-care services, telemedicine visits, and remote clinical trials have grown in importance, fostering demand for reliable, patient-operated sampling solutions. This demand has, in turn, catalyzed investments in educational resources, user-friendly packaging, and digital support that guide non-specialist users through collection. The net effect is a widening addressable application set for microsampling beyond simple screening and into longitudinal pharmacokinetic and therapeutic drug monitoring contexts.

Regulatory and reimbursement landscapes are also adapting, with authorities providing more detailed guidance on sample integrity and process validation for alternative matrices. Strategic partnerships between device manufacturers and analytical laboratories have become more frequent, and these collaborations are accelerating method transfer, validation exercises, and real-world usability studies. Together, these dynamics are elevating microsampling from proof-of-concept demonstrations to integrated elements of clinical and diagnostic workflows.

How evolving U.S. tariff dynamics are reshaping supply chain, sourcing and production decisions for manufacturers and distributors of microsampling devices and consumables

Recent tariff developments in the United States have introduced additional layers of complexity for companies that manufacture or distribute microsampling devices and associated consumables. Changes in import duty structures and classification guidance for medical devices and laboratory components affect cost bases for suppliers that rely on cross-border supply chains, particularly for precision parts, polymers, and specialty reagents. These adjustments have prompted procurement teams to reassess sourcing strategies and inventory policies to preserve margin and service levels.

Consequently, some firms have shifted toward nearshoring or establishing regional distribution and manufacturing partnerships to mitigate duty exposure and to reduce lead-time variability. These efforts are often accompanied by a reassessment of product architectures to minimize components subject to higher tariffs, and by renegotiations of commercial terms with suppliers and logistics providers. From an operational standpoint, supply chain contingency planning and enhanced visibility into supplier footprints have become priorities for organizations that require uninterrupted access to critical devices and consumables.

For buyers and end users, the tariff-induced cost dynamics underscore the need for rigorous total-cost-of-ownership analysis that accounts for duties, freight, inventory carrying, and potential quality control overheads arising from new sourcing relationships. Meanwhile, regulatory compliance and product registration timelines can influence where manufacturers prioritize localized production or warehousing. In sum, tariff shifts are encouraging a more deliberate alignment of commercial, regulatory, and supply chain strategies across the microsampling ecosystem.

Segment-specific analysis that clarifies product, channel, and end-user implications to guide strategic prioritization and adoption strategies across microsampling solutions

A granular view of segmentation reveals where clinical utility, adoption barriers, and commercial opportunity intersect across device and channel configurations. When the market is examined through sample-type distinctions-capillary sampling, dried blood spot, microfluidic cartridge, and volumetric absorptive microsampling-each approach presents unique analytical compatibility and user-experience considerations. Within the microfluidic cartridge subset, the divergence between automated sampler solutions and lab-on-a-chip architectures highlights trade-offs between throughput and point-of-care applicability. Similarly, among volumetric absorptive microsampling options, platform-specific implementations such as Capitainer, HemaXis, and Mitra reflect varying degrees of instrument dependence, user training requirements, and analyte stability profiles.

Assessing end users-contract research organizations, diagnostic laboratories, home care providers, hospitals, pharmaceutical companies, and research institutes-illuminates differences in adoption drivers and operational constraints. Contract research organizations and pharmaceutical companies tend to prioritize standardization and regulatory traceability to support multisite studies, whereas home care and point-of-care settings emphasize ease of use and patient instruction. Diagnostic laboratories and hospitals focus on integration with existing pre-analytical workflows and compatibility with downstream assays, while research institutes often value flexibility for experimental protocols.

Distribution channels-direct sales, distributors, and online channels-shape how solutions reach end users and influence service offerings such as training, validation support, and inventory management. Direct sales models enable deeper technical collaboration for customized deployments, distributors can provide regional reach and regulatory navigation, and online channels offer scalability for consumables and standardized kit offerings. Product-type segmentation across accessories, consumables, devices, and kits further clarifies commercial dynamics: accessories and consumables require high-frequency replenishment and logistics optimization, devices often represent capital investments with longer replacement cycles, and kits bundle components to simplify adoption in decentralized contexts. Understanding these interconnected segmentation layers is essential for designing go-to-market strategies and prioritizing product development trajectories.

Regionally differentiated product, regulatory and distribution imperatives that influence commercialization, validation and operational readiness for microsampling technologies

Regional dynamics significantly influence product design choices, regulatory preparation, and commercial go-to-market tactics. In the Americas, emphasis on decentralized clinical trials and a growing home-care infrastructure create demand for user-friendly sampling modalities and robust logistics solutions that can handle dispersed collection points. Regulatory pathways in the region are evolving to address alternative matrices and remote sampling, which in turn affects how suppliers structure validation packages and customer support offerings.

Across Europe, the Middle East & Africa, heterogeneous healthcare systems and diverse regulatory regimes necessitate adaptable market entry strategies. In some European markets, stringent laboratory accreditation requirements and centralized healthcare procurement demand rigorous method validation and strong local partnerships. Meanwhile, in parts of the Middle East & Africa, infrastructure constraints and variable access to cold-chain logistics shape the appeal of modalities that minimize sample fragility and simplify transport.

The Asia-Pacific region presents a combination of rapid adoption in urban centers and uneven capabilities across geographies. High-volume clinical trial activity and expanding diagnostic testing capacity in several countries have increased appetite for scalable microsampling solutions, while other markets require education and adaptation to local clinical workflows. Across all regions, successful commercialization depends on aligning device specifications with regional clinical practices, regulatory expectations, and distribution architectures that can ensure both availability and technical support.

Competitive landscape insights emphasizing differentiation in device precision, validation partnerships, and service-rich commercial models that influence vendor selection and adoption velocity

Competitive dynamics in the microsampling ecosystem reflect a mix of specialized device innovators, large diagnostics firms expanding portfolios, and contract testing laboratories that validate and standardize workflows. Product differentiation frequently centers on precision of volumetric capture, hematocrit mitigation strategies, user ergonomics, and integration capability with laboratory automation. Companies that combine strong usability with clear analytical performance and robust validation data tend to gain preference among clinical and research customers.

Strategic collaborations are common, with manufacturers partnering with clinical laboratories, pharmaceutical sponsors, and technology providers to accelerate validation and to build evidence for specific use cases. These partnerships help to close gaps in analytical validation and to create shared protocols that support wider adoption. In parallel, organizations investing in manufacturing redundancy and regulatory expertise are better positioned to respond to regional registration requirements and to offer shorter lead times to customers.

Investment patterns suggest that firms concentrating on modular platforms, scalable consumables supply chains, and service-oriented offerings-such as method transfer assistance and training programs-are establishing durable value propositions. For buyers, the vendor landscape requires careful due diligence around product lifecycle management, roadmap transparency, and the availability of post-sale technical support to ensure long-term operability and compliance with evolving laboratory standards.

Actionable strategic priorities for aligning product design, validation rigor, supply resilience and channel execution to convert microsampling potential into sustained adoption

Leaders evaluating strategic options should focus on practical steps that align product development, regulatory strategy, and commercial execution with real-world adoption constraints. Prioritize investments in usability testing and human factors engineering to reduce training overhead and to ensure reliable patient-collected samples. Coupling these efforts with rigorous method validation studies and transparent documentation will shorten adoption cycles among diagnostic laboratories and clinical sponsors.

Consider establishing regional manufacturing or distribution arrangements to mitigate duty exposure and to improve fulfillment responsiveness. Parallel investments in supply chain visibility tools and quality oversight will reduce the operational risk associated with complex, cross-border component sourcing. Commercial strategies should emphasize bundled solutions-devices with validated consumables and accessible technical support-to lower the barrier to adoption for hospitals, home-care providers, and decentralized trial operators.

Finally, pursue partnerships that accelerate evidence generation, such as collaborations with contract research organizations and research institutes to publish reliability and concordance data. These alliances provide credible third-party validation that can influence procurement committees and regulatory reviewers. By aligning product design, validation rigor, and channel support to user needs, industry leaders can convert the current momentum in microsampling into sustained clinical and commercial adoption.

A rigorous synthesis of primary interviews, technical literature, regulatory guidance and operational case studies designed to produce reproducible, decision-ready insights

This research synthesizes primary interviews, technical literature, regulatory guidance, and operational case studies to construct a comprehensive picture of the microsampling landscape. Primary inputs include structured interviews with laboratory directors, clinical operations leads, home-care program managers, and procurement specialists across healthcare and life-science organizations. These voices provide perspective on usability challenges, integration needs, and validation priorities that complement technical performance data.

Secondary sources include peer-reviewed publications, standards documents, and methodological white papers that describe assay compatibility, pre-analytical considerations, and device engineering principles. The synthesis emphasizes cross-validation among multiple information sources to reduce bias and to ensure that findings reflect consistent patterns rather than isolated anecdotes. Analytical methods prioritize qualitative triangulation, scenario-based impact assessment, and vendor capability mapping to identify robust strategic insights.

Throughout the research process, attention was paid to ensuring reproducibility of validation claims and to clarifying regulatory expectations in principal jurisdictions. The methodology also incorporated a review of supply chain configurations and tariff implications to capture operational realities that can influence time-to-deployment. Together, these methods provide a balanced, practice-oriented foundation for the conclusions and recommendations presented.

Synthesis of technological maturity, operational readiness and collaborative validation that will determine long-term clinical acceptance and deployment of microsampling solutions

Microsampling is positioned at an inflection point where technical maturity, decentralized care trends, and operational pragmatism intersect. The accumulated progress in device performance and microfluidic integration has expanded the practical use cases for capillary and volumetric approaches, while improvements in user support and training have reduced barriers to patient-collected sampling. At the same time, distribution networks and supply chain resilience carry increased importance as tariff and logistics dynamics influence cost and availability.

Stakeholders that align product development with rigorous validation, clear regulatory documentation, and targeted channel strategies will be best placed to capture the operational and clinical benefits of microsampling. Collaborative evidence generation remains a critical enabler, with partnerships between device developers, laboratories, and sponsors accelerating acceptance in clinical and diagnostic workflows. Ultimately, the future trajectory will be shaped by the degree to which the industry can standardize pre-analytical processes, demonstrate analytical equivalence where appropriate, and deliver consistent user experiences that translate into reliable specimens for downstream analytics.

In this environment, strategic clarity and operational discipline-rooted in validated performance and dependable supply arrangements-will determine which organizations convert early promise into long-term impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Microsampling Devices Market, by Product Type

  • 8.1. Accessories
  • 8.2. Consumables
  • 8.3. Devices
  • 8.4. Kits

9. Microsampling Devices Market, by Sample Type

  • 9.1. Capillary Sampling
  • 9.2. Dried Blood Spot
  • 9.3. Microfluidic Cartridge
    • 9.3.1. Automated Sampler
    • 9.3.2. Lab On A Chip
  • 9.4. Volumetric Absorptive Microsampling
    • 9.4.1. Capitainer
    • 9.4.2. HemaXis
    • 9.4.3. Mitra

10. Microsampling Devices Market, by End User

  • 10.1. Contract Research Organizations
  • 10.2. Diagnostic Laboratories
  • 10.3. Home Care
  • 10.4. Hospitals
  • 10.5. Pharmaceutical Companies
  • 10.6. Research Institutes

11. Microsampling Devices Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributors
  • 11.3. Online Channels

12. Microsampling Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Microsampling Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Microsampling Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Microsampling Devices Market

16. China Microsampling Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Agilent Technologies, Inc.
  • 17.6. AptarGroup, Inc.
  • 17.7. Bio-Rad Laboratories, Inc.
  • 17.8. Capitainer AB
  • 17.9. Cardinal Health, Inc.
  • 17.10. HemaXis
  • 17.11. HTL-STREFA S.A.
  • 17.12. LGC Limited
  • 17.13. Medtronic plc
  • 17.14. Merck KGaA
  • 17.15. Neoteryx LLC
  • 17.16. Nipro Corporation
  • 17.17. Owen Mumford Ltd.
  • 17.18. PerkinElmer, Inc.
  • 17.19. Phenomenex, Inc.
  • 17.20. Sarstedt AG & Co. KG
  • 17.21. Shimadzu Corporation
  • 17.22. Siemens Healthineers AG
  • 17.23. Spot On Sciences, Inc.
  • 17.24. Tasso, Inc.
  • 17.25. Terumo Corporation
  • 17.26. Thermo Fisher Scientific, Inc.
  • 17.27. Trajan Scientific and Medical Pty Ltd
  • 17.28. West Pharmaceutical Services, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MICROSAMPLING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MICROSAMPLING DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MICROSAMPLING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MICROSAMPLING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY CAPILLARY SAMPLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY CAPILLARY SAMPLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY CAPILLARY SAMPLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DRIED BLOOD SPOT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DRIED BLOOD SPOT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DRIED BLOOD SPOT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY AUTOMATED SAMPLER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY AUTOMATED SAMPLER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY AUTOMATED SAMPLER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY LAB ON A CHIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY LAB ON A CHIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY LAB ON A CHIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY CAPITAINER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY CAPITAINER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY CAPITAINER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY HEMAXIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY HEMAXIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY HEMAXIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY MITRA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY MITRA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY MITRA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS MICROSAMPLING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. GCC MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GCC MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. GCC MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. GCC MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 143. GCC MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 144. GCC MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. GCC MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. G7 MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. G7 MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. G7 MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. G7 MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 164. G7 MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 165. G7 MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. G7 MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. NATO MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. NATO MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. NATO MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. NATO MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 171. NATO MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 172. NATO MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. NATO MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL MICROSAMPLING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES MICROSAMPLING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA MICROSAMPLING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA MICROSAMPLING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA MICROSAMPLING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA MICROSAMPLING DEVICES MARKET SIZE, BY MICROFLUIDIC CARTRIDGE, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA MICROSAMPLING DEVICES MARKET SIZE, BY VOLUMETRIC ABSORPTIVE MICROSAMPLING, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA MICROSAMPLING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA MICROSAMPLING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)